Loading...
•
Dec 31, 2023
Rxsight Q4 2023 Earnings Report
RxSight's Q4 2023 earnings report showed significant revenue growth driven by increased sales of both Light Delivery Devices (LDDs) and Light Adjustable Lenses (LALs).
Key Takeaways
RxSight, Inc. reported a strong fourth quarter in 2023, with a 78% increase in revenue compared to the same period in 2022. This growth was fueled by increased sales of LDDs and LALs. The company's gross profit also saw a substantial increase, although it reported a net loss for the quarter.
Revenue increased by 78% compared to Q4 2022, reaching $28.6 million.
LDD sales increased by 35% in units, expanding the installed base to 666 LDDs.
LAL sales increased by 98% in procedure volumes.
Gross profit increased by 138% compared to Q4 2022, reaching $17.7 million.
Forward Guidance
The company reiterated its full-year 2024 guidance for revenue, gross profit margin and operating expenses.
Positive Outlook
- Revenue guidance range of $128.0 million to $135.0 million, representing implied growth of 44% to 52% compared to 2023.
- Gross margin guidance range of 65% to 67%, representing an implied increase of 500 bps to 700 bps compared to 2023.
- Operating expense guidance range of $125.0 million to $128.0 million, representing an implied growth of 20% to 23% compared to 2023.
- Non-cash expense guidance in the range of $22.0 million to $25.0 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...